• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Catalog Number 1125350-38
Health Effect - Clinical Codes Low Blood Pressure/ Hypotension (1914); Perforation (2001)
Date of Event 02/10/2017
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
(b)(4).Concomitant medical products: guide wire: sion, sion blue; guide catheter: hyperion sal 7f, stent: xience alpine 3.0x18mm, 4.0 x28mm, graftmaster 2.8x19mm.The device was not returned for analysis.However, hypotension and arterial perforation are listed in the xience alpine everolimus eluting coronary stent systems instructions for use as known patient effects of coronary stenting procedures.The investigation determined a conclusive cause for the reported difficult to position cannot be determined.Additionally, a conclusive cause for the reported patient effect(s), and the relationship to the product, if any, cannot be determined.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other similar incidents from this lot.There is no indication of a product quality issue with respect to manufacture, design or labeling.The 2.8 x 19 graftmaster is being filed under a separate medwatch report number.
 
Event or Problem Description
It was reported that the procedure was to treat a mildly tortuous and moderately calcified, de novo and eccentric proximal right coronary artery (rca) that was 90% stenosed.Pre-dilatation was performed with two non-abbott balloon catheters.A 3.0 x 18 mm xience alpine stent was deployed in the distal rca, a 3.5 x 38 mm xience alpine stent was deployed in the mid rca and a 4.0 x 28 mm xience alpine stent was deployed in the proximal rca.The 3.0 x 18 mm and 3.5 x 38 mm stents were not overlapped, the 3.5 x 38 mm and 4.0 x 28 mm were overlapped.Intravascular ultrasound (ivus) was used multiple times before and after deploying the stents.It was confirmed there was no malposition of the 3.5 x 38 mm xience alpine; however, it was oval shaped due to the calcified lesion.Angiography was performed due to the patient blood pressure declining and a perforation was noted where the 3.5 x 38 mm xience alpine was implanted.Pericardiocentesis was performed and a 2.8 x 19 mm graftmaster covered stent system was advanced but could not cross through the implanted 3.5 x 38 mm xience alpine and when removed from the anatomy the edge of the stent was flared.A guideliner was advanced and a 2.8 x 16 mm graftmaster was deployed to cover the perforation.There was no leak noted.An additional 3.5 x 16 mm graftmaster stent was deployed overlapping the proximal end of the 3.5 x 38 mm xience alpine.Post-dilatation was performed with a non-abbott balloon catheter and ivus was performed to confirm there was no blood leak which completed the procedure.There was a clinically significant delay in the procedure.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Common Device Name
DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
MDR Report Key6393818
Report Number2024168-2017-01988
Device Sequence Number13461337
Product Code NIQ
UDI-Device Identifier08717648199578
UDI-Public(01)08717648199578(17)191108(10)6110141
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
P110019
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2017
Reporter Type Manufacturer
Report Source company representative,foreig
Initial Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial
Report Date (Section B) 03/09/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date11/08/2019
Device Catalogue Number1125350-38
Device Lot Number6110141
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/13/2017
Initial Report FDA Received Date03/09/2017
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age72 YR
Patient Weight58
-
-